Navigation Links
Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
Date:2/3/2009

SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Eric Lai, Ph.D., has joined the Company as senior vice president, research and development.

"We are very pleased to add Eric's scientific expertise and leadership to our already strong senior management team," said Carl Hull, Gen-Probe's president and chief operating officer. "We believe Eric will play an integral role in helping our R&D team drive short-, medium- and long-term product sales growth for the Company."

Dr. Lai, 51, was most recently vice president, pharmacogenetics experimental project coordination and analysis, at GlaxoSmithKline (GSK). He was previously GSK's vice president for discovery and pipeline genetics. Before joining GSK in 1995, he was an assistant professor in the department of pharmacology at the University of North Carolina at Chapel Hill.

Dr. Lai earned a Ph.D. in pharmacology and microbiology from Columbia University, M. Phil. and M.A. degrees from the department of pharmacology at Columbia, and a B.S. in chemistry from the University of Waterloo in Ontario, Canada.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to www.gen-probe.com.

<
'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
2. NewCardio Joins the Cardiac Safety Research Consortium
3. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
4. Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
5. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
6. David Bagley Joins Histogen as President
7. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
8. Dr Stephan Rietiker Joins BioCeramic Therapeutics
9. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
10. GEN Joins Charles Darwin 2009 Celebration
11. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... California waste-to-energy firm claims first pla...ration, smallest footprint, salable pure gas, bypr... (PRWEB) December 15, 2009 -- The f...ive organic waste-to-energy process will take plac...ary. , , ,This biowaste process known as VRAD&cop...
(Date:11/30/2009)...hio, Nov. 30 The Ohio Capital Fund...on,s first minority business early-stage capital s...er 3, is called "Transforming the Landscape of Bus...Capital Summit." It will feature several speakers ...aders and local minority entrepreneurs. ,, "Th...
(Date:11/30/2009)... OF PRUSSIA, Pa., Nov. 30 Cadient...ing in interactive marketing services and solutio...e launch of its HATCH Consulting services gr...g strategic experts across a range of emerging are...sulting team is committed to guiding companies and...
(Date:11/30/2009)...ov. 30 The Michael J. F...y announced $1.5 million in total awards to six re...e-modifying therapies for Parkinson,s disease. The...o Drug Discovery for Parkinson,s Disease program,...lc (NYSE: ELN ), a neuroscience-based biotechnol...
Breaking Biology Technology:First Public Showing of Innovative Waste-to-Energy Process 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3
... of Immunosyn Corporation (OTC Bulletin Board: IMY... http://www.wallst.net scheduled for November 16... http://www.wallst.net by 5 P.M. EST,on November...ing Immunosyn,s market potential,growth initiative...at,investors should watch for. "This interview is...
...eported today that it has filed a Form 12b-25 with... that its Form 10-QSB for the six months,ended Sep... 2007. However,AMDL expects to file the required r...y the Rules. Gary L. Dreher, President, stated: "A...ng and we need the additional time to,properly pre...
...e,Company (H&V), a leading global provider of nonw...ision(TM) technology platform, a collaborative,pro...rcialization of,breakthrough products. "HVision w...ed on,creating a new generation of products that e...ry," said Val Hollingsworth, H&V,s President and,C...
Other Biology Technology:WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation 2WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation 3AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB 2H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products 2
(Date:11/30/2009)...ontinue to rise scientists are presented with the ...pond and adapt. In a paper published in Insect Co...Trelles and Dr Miguel Rodriguez assess this challe...ximately 0.6˚C has already affected the Earth...ists and evolutionary biologists is to predict how...
(Date:11/30/2009)...research is the virus,s exquisite specialisation f...ional tools, like the humble lab mouse, can delive...hers writing in BioMed Central,s open access Jour...this problem by creating a mouse that has key feat...HIV. , George Kassiotis, from the Division of Im...
(Date:11/30/2009)...blished in the December 2009 print issue of The F...of control over their fertility that women have ha...found how and where androgenic hormones work in th...le fertility. This opens a promising avenue for th... also offers hope to those who cannot have childre...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2Abbott Declares 343rd Consecutive Quarterly Dividend 14129 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 1Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 3
...ntrols blood sugar,s manufacture in a novel way: b...findings are reported in the April issue of the jo...The study found that mice deficient for KLF15, a m...scription factors, become severely lacking in the ...e body and the sole source for the brain—after a p...
...(IAVI) January 2007 Annual Issue of VAX, an editor...h published by IAVI, reports that 13 new preventiv...tries around the world in 2006. There are now more...ery continent. , This annual publication provides...e clinical trial activity worldwide. , Last yea...
...t wheat variety have led to a major advance in bre...et of papers published in the journal Plant Physio...s Nax1 and Nax2. The genes work by excluding salt ...ots, the other from the leaves. The discovery of t...ts. , "The two genes originally came from a whe...
Other Biology News:Blood sugar's manufacture limited by building blocks' supply 230+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent 2Ancient genes used to produce salt-tolerant wheat 2
BD BioCoat Gelatin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
BD Falcon Standard Cell Culture Dish from BD Biosciences - Discovery Labware
BD BioCoat Laminin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: